Agios Pharmaceuticals faces major competitive and regulatory headwinds in sickle cell disease and thalassemia, leading to a rating downgrade to a cautious 'Hold.' Novo Nordisk's PK activator looks ...
Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene therapies, ...
When a gene is turned on in a cell, it creates a ripple effect along the DNA strand, changing the physical structure of the ...
U.S. Mitapivat Net Revenue -- $18.8 million, attributed to initial AQVESME demand. Operating Expenses -- R&D was $81 million, ...
People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked.
Operator: Good day, and thank you for standing by. Welcome to the First Quarter 2026 Agios Financial Results and Business ...
Pamper Your Mom with Lotus Facial Kit for a Radiant Glow on Mother's Day 2026 The Lotus facial kit is formulated to offer a ...
A new study links fatty acid metabolism to rheumatoid arthritis treatment, revealing a natural compound that disrupts ...
Researchers are uncovering how X chromosome inactivation and Xi expressed genes may contribute to autism’s sex bias, offering ...
Scientists have discovered that increased expression of a novel long non-coding RNA drives glioblastoma cell growth alongside a genetic amplification found in more than half of glioblastoma tumors, ...
1. It protects skin cells from free radicals and UV damage. 2. It strengthens the skin’s moisture barrier – prevents dryness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results